| Key Financial Ratios of Beta Drugs (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
7.49 |
8.92 |
7.82 |
42.27 |
11.23 |
|
| Diluted EPS (Rs.) |
7.49 |
8.92 |
7.82 |
4.94 |
11.23 |
|
| Cash EPS (Rs.) |
10.07 |
11.72 |
9.96 |
54.53 |
23.50 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
58.71 |
46.93 |
38.02 |
60.11 |
21.79 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
58.71 |
46.93 |
38.02 |
60.11 |
21.79 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
67.94 |
67.11 |
58.46 |
412.40 |
261.16 |
|
| PBDIT/Share (Rs.) |
12.66 |
12.28 |
11.22 |
72.38 |
30.05 |
|
| PBIT/Share (Rs.) |
9.98 |
9.48 |
9.08 |
60.12 |
17.78 |
|
| PBT/Share (Rs.) |
9.31 |
8.63 |
7.90 |
51.99 |
11.23 |
|
| Net Profit/Share (Rs.) |
7.39 |
8.92 |
7.82 |
42.27 |
11.23 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
18.62 |
18.30 |
19.18 |
17.55 |
11.50 |
|
| PBIT Margin (%) |
14.68 |
14.12 |
15.52 |
14.57 |
6.80 |
|
| PBT Margin (%) |
13.70 |
12.86 |
13.51 |
12.60 |
4.29 |
|
| Net Profit Margin (%) |
10.86 |
13.28 |
13.37 |
10.24 |
4.29 |
|
| Return on Networth / Equity (%) |
12.57 |
19.00 |
20.56 |
70.32 |
51.51 |
|
| Return on Capital Employed (%) |
15.77 |
17.78 |
21.78 |
59.74 |
18.40 |
|
| Return on Assets (%) |
8.63 |
11.93 |
13.64 |
18.39 |
7.45 |
|
| Total Debt/Equity (X) |
0.13 |
0.16 |
0.19 |
1.24 |
3.52 |
|
| Asset Turnover Ratio (%) |
79.45 |
89.78 |
101.98 |
179.44 |
173.49 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.73 |
1.72 |
2.39 |
1.16 |
0.86 |
|
| Quick Ratio (X) |
1.45 |
1.37 |
2.18 |
0.97 |
0.55 |
|
| Inventory Turnover Ratio (X) |
10.71 |
9.06 |
18.04 |
17.38 |
9.23 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
41.71 |
94.07 |
103.42 |
0.00 |
0.00 |
|
| EV/Net Operating Revenue (X) |
0.64 |
1.62 |
2.05 |
0.00 |
0.00 |
|
| EV/EBITDA (X) |
3.43 |
8.86 |
10.66 |
0.00 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
0.59 |
1.56 |
2.16 |
0.00 |
0.00 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
0.68 |
2.23 |
3.31 |
0.00 |
0.00 |
|
| Price/Net Operating Revenue |
0.59 |
1.56 |
2.16 |
0.00 |
0.00 |
|
| Earnings Yield |
0.18 |
0.09 |
0.06 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
